Vivos Therapeutics, Inc. (VVOS)
0.1864
+0.01
(+6.76%)
USD |
NASDAQ |
Sep 04, 16:00
0.1771
-0.01
(-4.99%)
After-Hours: 20:00
Vivos Therapeutics Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.10M |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | 0.10M |
| June 30, 2023 | 0.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Hinge Health, Inc. | 34.06M |
| Exlites Holdings International, Inc. | -- |
| Xcelerate, Inc. | -- |
| Haemonetics Corp. | 16.21M |
| Pro-Dex, Inc. | 1.017M |